[PTGX] YoY Quarter Result on 30-Jun-2016 [#Q2]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
15-Sep-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- 39.58%
YoY- -120.50%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 2,265 6,217 -8,189 11,674 0 0 0 -
PBT -30,842 -18,292 -30,803 -8,663 -14,979 -7,098 -3,219 45.68%
Tax -57 1,129 -1,629 0 0 -27 136 -
NP -30,842 -19,421 -29,174 -8,663 -14,979 -7,098 -3,219 45.68%
Tax Rate - - - - - - - -
Total Cost 33,107 25,638 20,985 20,337 14,979 7,098 3,219 47.41%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin -1,361.68 -312.39 356.26 -74.21 0.00 0.00 0.00 -
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS -0.69 -0.59 -1.18 -0.41 -0.89 -0.43 -0.55 3.84%
EPS Diluted -0.69 -0.59 -1.18 -0.41 -0.89 -0.43 -0.55 3.84%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.